(Q34285979)

1 August 2017

1 reference

title

Pharmacogenomics: will it change the field of medicine? (English)

1 reference

1 August 2017

1 reference

Wieczorek SJ

1

1 reference

PubMed ID

11412811

1 August 2017

Tsongalis GJ

series ordinal

2

1 reference

1 August 2017

1 June 2001

1 reference

1 August 2017

1 reference

1 August 2017

308

1 reference

1 August 2017

1-8

1 reference

1 August 2017

1-2

1 reference

Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Populations and genetic polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Metabolic effects of pyrimidines derived from fava bean glycosides on human erythrocytes deficient in glucose-6-phosphate dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Pharmacogenetics of alcohol sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Accumulation of acetaldehyde in alcohol-sensitive Japanese: relation to ethanol and acetaldehyde oxidizing capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

The effect of β73Asn on the interactions of sickling hemoglobins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Apolipoprotein E Alleles and Risk of Coronary Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction : a substudy of the Scandinavian simvastatin survival study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Molecular genetics of the P-450 superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Molecular basis of cardiovascular drug metabolism: implications for predicting clinically important drug interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Applications of primary human hepatocytes in the evaluation of pharmacokinetic drug-drug interactions: evaluation of model drugs terfenadine and rifampin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Clinical pharmacokinetics of mibefradil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Rhabdomyolysis due to interaction of simvastatin with mibefradil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Clinical pharmacokinetics of troglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co-medication interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Review article: cardiac adverse effects of gastrointestinal prokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Role of P-glycoprotein in drug disposition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: A report from the cystic fibrosis genetic analysis consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Pharmacology of CFTR chloride channel activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Molecular and genetic basis of beta2-adrenergic receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Polymorphisms of the beta2-adrenergic receptor and asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Plasma histamine, epinephrine, cortisol, and leukocyte beta-adrenergic receptors in nocturnal asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Association of Glu 27 beta 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Genomics, genes, and environmental interaction: the role of exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Exercise training-induced blood pressure and plasma lipid improvements in hypertensives may be genotype dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Apolipoprotein E genotype and exercise training-induced increases in plasma high-density lipoprotein (HDL)- and HDL2-cholesterol levels in overweight men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

Multidrug-resistance transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900419-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-8981(01)00419-3

1 reference

1 August 2017

1 reference

PubMed ID

11412811